Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) represents 25–30% of all CRS cases, and in the most severe forms it is associated with a poor quality of life and a high rate of nasal polyps’ recurrence after surgery. Dupilumab has been suggested as a treatment option for severe CRSwNP....

Descripción completa

Detalles Bibliográficos
Autores principales: Ottaviano, Giancarlo, Saccardo, Tommaso, Roccuzzo, Giuseppe, Bernardi, Riccardo, Chicco, Alessandra Di, Pendolino, Alfonso Luca, Scarpa, Bruno, Mairani, Edoardo, Nicolai, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502990/
https://www.ncbi.nlm.nih.gov/pubmed/36143311
http://dx.doi.org/10.3390/jpm12091526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502990/
https://www.ncbi.nlm.nih.gov/pubmed/36143311
http://dx.doi.org/10.3390/jpm12091526

Ejemplares similares